We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$657B
AUM Growth
+$81.2B
Cap. Flow
+$16.8B
Cap. Flow %
2.56%
Top 10 Hldgs %
24.92%
Holding
14,587
New
2,292
Increased
5,364
Reduced
4,887
Closed
1,963

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.45B
2
V icon
Visa
V
+$1.05B
3
MSFT icon
Microsoft
MSFT
+$1.01B
4
AAPL icon
Apple
AAPL
+$578M
5
NSC icon
Norfolk Southern
NSC
+$545M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.24B
2
MCD icon
McDonald's
MCD
+$707M
3
JPM icon
JPMorgan Chase
JPM
+$680M
4
TXN icon
Texas Instruments
TXN
+$678M
5
EW icon
Edwards Lifesciences
EW
+$664M

Sector Composition

Rank Sector Weight
1 Technology 3.8%
2 Healthcare 2.66%
3 Financials 2.38%
4 Consumer Discretionary 2.05%
5 Industrials 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATL icon
12226
Battalion Oil
BATL
$30.4M
$42.6K ﹤0.01%
35,173
+10,189
+41% +$12.5K
FARM
12227
DELISTED
Farmer Brothers
FARM
$42.5K ﹤0.01%
24,864
-82,867
-77% -$144K
FATE icon
12228
CALL
Fate Therapeutics
FATE
$308M
$42.3K ﹤0.01%
33,600
-27,500
-45% -$29.7K
ALMS
12229
CALL
Alumis Inc
ALMS
$3.28B
$42.3K ﹤0.01%
10,600
-96,000
-90% -$395K
IMUX icon
12230
PUT
Immunic
IMUX
$219M
$42.2K ﹤0.01%
4,790
+3,010
+169% +$26.5K
OABI icon
12231
CALL
OmniAb
OABI
$491M
$41.9K ﹤0.01%
+26,200
New +$47.9K
LHSW
12232
Lianhe Sowell International Group
LHSW
$9.55M
$41.9K ﹤0.01%
+1,264
New +$48.1K
SLAI
12233
PUT
DELISTED
SOLAI Ltd ADS
SLAI
$41.9K ﹤0.01%
2,214
+757
+52% +$15.8K
MGF
12234
Aberdeen Government Markets Income Fund
MGF
$92.6M
$41.7K ﹤0.01%
13,361
-12,166
-48% -$37.6K
PLTK icon
12235
CALL
Playtika
PLTK
$957M
$41.6K ﹤0.01%
10,700
-6,200
-37% -$25.3K
JSPR icon
12236
PUT
Jasper Therapeutics
JSPR
$26.3M
$41.4K ﹤0.01%
17,400
-100
-0.6% -$303
MMLP icon
12237
Martin Midstream Partners
MMLP
$93.9M
$41.3K ﹤0.01%
+13,490
New +$42.2K
ISPR icon
12238
Ispire Technology
ISPR
$89M
$41.3K ﹤0.01%
+16,116
New +$46.8K
AUTL
12239
PUT
Autolus Therapeutics
AUTL
$572M
$41.2K ﹤0.01%
25,300
-3,400
-12% -$6.64K
MDIA icon
12240
Mediaco Holding
MDIA
$78.6M
$41.1K ﹤0.01%
+32,354
New +$42.3K
TRIB
12241
Trinity Biotech
TRIB
$7.88M
$41K ﹤0.01%
+1,313
New +$41.4K
GNTA
12242
Genenta Science
GNTA
$62.7M
$41K ﹤0.01%
+12,486
New +$44.2K
MEGL icon
12243
Magic Empire Global Ltd
MEGL
$6.23M
$40.9K ﹤0.01%
+26,900
New +$40.2K
GITS
12244
Global Interactive Technologies
GITS
$7.09M
$40.8K ﹤0.01%
+17,900
New +$43.6K
ZBAO
12245
Zhibao Technology Inc
ZBAO
$7.71M
$40.8K ﹤0.01%
40,774
-21,922
-35% -$22.3K
LPCN icon
12246
Lipocine
LPCN
$17.4M
$40.7K ﹤0.01%
+14,247
New +$43.3K
BLIN icon
12247
Bridgeline Digital
BLIN
$12.6M
$40.7K ﹤0.01%
+31,069
New +$43.8K
ROLR
12248
High Roller Technologies
ROLR
$62.6M
$40.5K ﹤0.01%
+14,472
New +$39.9K
FLNA
12249
Filana Therapeutics
FLNA
$44.1M
$40.3K ﹤0.01%
+13,864
New +$31.9K
EPWK
12250
DELISTED
EPWK Holdings
EPWK
$40.3K ﹤0.01%
2,516
-868
-26% -$16.2K

Similar funds

Ken Griffin's Q3 2025 Portfolio in Review

As of Q3 2025, Ken Griffin held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin's Q3 2025 filing shows 2,292 new, 5,364 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
  • Ken Griffin's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
  • Ken Griffin fully exited Hess in Q3 2025, selling an estimated $1.24B.
  • Ken Griffin's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
  • Ken Griffin opened 2,292 new positions and closed 1,963 in Q3 2025.
  • Ken Griffin's portfolio value rose 14% quarter-over-quarter to $657B.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.